Stem Cell Therapy in Thailand
Advanced regenerative treatments with personalised protocols, experienced clinicians, and dedicated support for international patients.
What is stem cell therapy?
Stem cell therapy harnesses the regenerative potential of mesenchymal stem cells to support tissue healing, reduce inflammation, and promote natural recovery. At Boston Health Longevity, all treatments use umbilical cord-derived MSCs (Wharton's Jelly), the gold standard in regenerative medicine for their potency, safety profile, and consistent quality.
Our clinical team in Chiang Mai delivers personalised treatment protocols developed under the direction of Dr Michael Ackland, MBBS (Hons), FRACGP, with over 40 years of clinical experience. Every patient receives a thorough assessment, a clear treatment plan, and transparent pricing before any commitment.
We specialise in treating international patients from across the globe, including Australia, Singapore, Hong Kong, the UAE, United Kingdom, Japan, and more. Our team handles everything from your initial consultation through to airport transfers, treatment, and long-term follow-up after you return home.
Medical Disclaimer: Results vary between individuals and cannot be guaranteed. This information does not constitute medical advice. Consult a qualified healthcare provider before making treatment decisions.
Umbilical cord-derived mesenchymal stem cells
All stem cell protocols at Boston Health Longevity use mesenchymal stem cells (MSCs) sourced exclusively from human umbilical cord tissue (Wharton's Jelly). Umbilical cord MSCs are considered the gold standard in regenerative medicine due to their youth, potency, and exceptional safety profile.
What are Mesenchymal Stem Cells (MSCs)?
Mesenchymal stem cells are multipotent progenitor cells capable of differentiating into multiple tissue types, including bone, cartilage, muscle, fat, and connective tissue. They are the most extensively researched cell type in regenerative medicine, with thousands of published clinical studies supporting their therapeutic potential across orthopaedic, neurological, autoimmune, cardiovascular, and metabolic conditions.
MSCs exert their therapeutic effects through two primary mechanisms: direct differentiation into the target tissue type, and paracrine signalling, where they release bioactive molecules (growth factors, cytokines, and exosomes) that modulate the local immune environment, reduce inflammation, promote tissue repair, and recruit the body's own regenerative cells to the treatment site.
Why Umbilical Cord Source?
Umbilical cord tissue (Wharton's Jelly) is collected from healthy, consenting donors following full-term caesarean deliveries. The tissue is processed under strict GMP (Good Manufacturing Practice) laboratory conditions to isolate, expand, and characterise MSCs before therapeutic use. This source offers significant advantages over other cell sources.
Highest Proliferative Capacity
Neonatal cells divide more rapidly and maintain potency for longer than adult-derived alternatives, producing higher viable cell counts per treatment.
Low Immunogenicity
Umbilical cord MSCs express minimal MHC class II markers, significantly reducing the risk of immune rejection and allowing allogeneic (donor) use without immunosuppression.
Superior Anti-Inflammatory Properties
Research indicates umbilical cord MSCs secrete higher concentrations of anti-inflammatory cytokines and immunomodulatory factors compared to bone marrow or adipose-derived cells.
Ethical and Non-Invasive Collection
Cord tissue is collected after delivery with full maternal consent. No invasive harvesting procedures are required from the patient, eliminating donor-site pain or risk.
Consistent Quality
Unlike autologous (self-sourced) cells, which decline with patient age, umbilical cord MSCs provide consistent cell quality regardless of the recipient's age or health status.
GMP Laboratory Processing
All cells are expanded and tested in certified GMP laboratories with full traceability, sterility testing, viability assays, and endotoxin screening before clinical use.
Quality assurance: Every batch of umbilical cord MSCs used at Boston Health Longevity undergoes rigorous testing including flow cytometry for surface marker expression (CD73+, CD90+, CD105+, CD34-, CD45-), sterility and mycoplasma testing, endotoxin assays, and karyotype analysis. Certificates of analysis are available upon request.
Lineage-programmed stem cells
At Boston Health Longevity, we go beyond standard mesenchymal stem cell therapy. Our clinical team utilises lineage-programmed stem cells that have been directed toward specific tissue repair pathways before delivery. This targeted approach may enhance therapeutic outcomes by ensuring cells are primed to address the precise needs of each condition.
Programming is achieved through controlled in-vitro culture conditions, specific growth factor cocktails, and validated differentiation protocols. Each batch undergoes quality assurance testing for viability, sterility, and lineage marker expression prior to clinical use.
Neurogenic Programmed Stem Cells
Neural Tissue Repair
Neurogenic programmed stem cells are mesenchymal stem cells that have been directed along neural differentiation pathways prior to therapeutic delivery. Through carefully controlled culture conditions and neurotrophic growth factor exposure, these cells are primed to support the repair and regeneration of neural tissue, including nerve fibres, glial cells, and neurovascular structures.
How They Work
- Express neural lineage markers (Nestin, MAP2, beta-III tubulin) indicating commitment to nerve tissue development
- Secrete elevated levels of neurotrophic factors (BDNF, NGF, GDNF) that may support existing neural cell survival and axonal growth
- May help modulate neuroinflammation and reduce secondary damage cascades following neural injury
- Support remyelination processes that may help restore signal conduction in damaged nerves
Clinical note: Neurogenic programming enhances the neuroregenerative potential of MSCs compared to unprogrammed cells. Published research suggests neurogenic MSCs demonstrate improved engraftment in neural tissue and more targeted secretion of neuroprotective factors. Individual outcomes vary based on condition severity, duration, and patient factors.
Vasculogenic Programmed Stem Cells
Vascular and Cardiovascular Repair
Vasculogenic programmed stem cells are MSCs that have been directed toward endothelial and vascular smooth muscle cell lineages. These cells are conditioned using angiogenic growth factor protocols (including VEGF, FGF, and angiopoietin exposure) to enhance their ability to support new blood vessel formation, improve microcirculation, and promote vascular tissue repair in damaged or ischemic areas.
How They Work
- Express endothelial markers (CD31, vWF, VEGFR2) indicating vascular lineage commitment and readiness for vessel formation
- Promote angiogenesis (new blood vessel formation) and arteriogenesis (maturation of existing collateral vessels) in ischemic tissues
- May improve microvascular perfusion and oxygen delivery to tissues affected by poor blood supply
- Support endothelial repair and may help restore normal vascular function, including vessel elasticity and nitric oxide production
Clinical note: Vasculogenic programming enhances the pro-angiogenic capacity of MSCs. Clinical literature suggests these cells demonstrate improved integration with host vasculature and increased secretion of VEGF and other angiogenic cytokines compared to unprogrammed MSCs. Outcomes are influenced by the degree of existing vascular damage, patient age, and comorbidities.
Chondrogenic Programmed Stem Cells
Cartilage and Joint Repair
Chondrogenic programmed stem cells are MSCs that have been directed toward cartilage-forming (chondrocyte) lineages using specific differentiation protocols. Through exposure to TGF-beta superfamily growth factors, BMP signalling molecules, and controlled three-dimensional culture conditions, these cells are primed to produce cartilage matrix components including type II collagen and aggrecan. This targeted approach aims to improve cartilage regeneration outcomes compared to using unprogrammed MSCs alone.
How They Work
- Express chondrogenic markers (SOX9, type II collagen, aggrecan) confirming cartilage lineage commitment before therapeutic delivery
- Produce hyaline-like cartilage matrix components that may help restore joint surface integrity and biomechanical function
- Secrete anti-inflammatory mediators that help reduce joint inflammation, synovitis, and further cartilage degradation
- May integrate with existing cartilage tissue to fill defects, improve joint space measurements, and reduce bone-on-bone contact
Clinical note: Chondrogenic programming directs MSCs toward cartilage-producing phenotypes before delivery into the joint. Published preclinical and early clinical data suggests chondrogenic-primed MSCs demonstrate superior cartilage matrix production and integration compared to naive MSCs. Results depend on the grade of cartilage loss, joint alignment, body weight, and patient compliance with post-treatment rehabilitation protocols.
Targeted cells for targeted outcomes
Standard stem cell therapy delivers unprogrammed MSCs to the treatment site. While effective, these cells must navigate their local environment to determine which tissue type to support. Lineage programming pre-commits cells to the relevant repair pathway before injection, potentially reducing the time to therapeutic effect and improving the precision of tissue regeneration.
Our clinical team selects the appropriate cell programming based on your specific condition, treatment goals, and clinical assessment findings. In many cases, combination protocols using multiple programmed cell types may be recommended to address complex or multi-system conditions.
Neurogenic
Brain, spine, and nerve repair
Vasculogenic
Heart, vessels, and circulation
Chondrogenic
Cartilage, joints, and tendons
Stem cells combined with exosome therapy
At Boston Health Longevity, we combine umbilical cord-derived mesenchymal stem cells with exosome therapy to enhance therapeutic outcomes. This dual approach leverages both the regenerative capacity of live stem cells and the powerful signalling molecules carried by exosomes, creating a synergistic treatment protocol.
We use two types of exosomes in our protocols: conventional MSC-derived exosomes and advanced iPSC exosomes. Your clinical team will recommend the appropriate combination based on your condition, treatment goals, and clinical assessment.
Enhanced Tissue Repair
Exosomes deliver concentrated growth factors and signalling molecules directly to damaged tissue, amplifying the regenerative effects of stem cell therapy.
Targeted Immunomodulation
Exosomes carry anti-inflammatory cytokines and microRNAs that may help regulate the immune response, reducing chronic inflammation at the cellular level.
Improved Cell Communication
Exosomes facilitate intercellular communication, helping transplanted stem cells integrate with existing tissue and coordinate the regenerative response more effectively.
Nano-Scale Delivery
Due to their nano-scale size (30-150nm), exosomes can cross biological barriers that whole cells cannot, potentially reaching tissues such as the central nervous system more effectively.
What are exosomes and iPSC exosomes?
Exosomes are a key component of how cells communicate. Understanding the difference between conventional and iPSC-derived exosomes helps explain why we use both in our protocols.
MSC-Derived Exosomes
Naturally released by mesenchymal stem cells
Exosomes are tiny extracellular vesicles (30-150 nanometres) naturally released by cells as part of normal biological communication. Think of them as parcels that cells send to one another, packed with bioactive cargo including proteins, lipids, mRNA, and microRNA.
When derived from mesenchymal stem cells, these exosomes carry the regenerative signalling molecules that give stem cells much of their therapeutic potential. Research suggests that a significant portion of the benefit from stem cell therapy comes not from the cells themselves directly integrating into tissue, but from the paracrine factors and exosomes they release.
MSC-derived exosomes may support tissue repair, modulate immune responses, reduce inflammation, and promote angiogenesis (new blood vessel formation). Because they are cell-free, they are stable, can be precisely dosed, and carry a lower immunogenicity risk compared to whole-cell therapies alone.
Key Cargo
iPSC Exosomes
Derived from induced pluripotent stem cells
iPSC exosomes are derived from induced pluripotent stem cells, which are adult cells that have been reprogrammed back to a pluripotent state (capable of becoming almost any cell type). This reprogramming gives iPSC exosomes a distinct and potentially more potent cargo profile compared to conventional MSC-derived exosomes.
Because iPSCs possess broader differentiation potential than adult MSCs, the exosomes they produce carry a richer array of regenerative signalling molecules, including factors associated with embryonic-like repair pathways. Early research suggests iPSC exosomes may demonstrate enhanced tissue regeneration, stronger anti-fibrotic effects, and improved cellular reprogramming signals compared to their MSC-derived counterparts.
iPSC exosomes represent the next generation of cell-free regenerative therapy. At Boston Health Longevity, we incorporate iPSC exosomes into select protocols where their enhanced signalling profile may offer additional clinical benefit, particularly for neurological conditions, cardiovascular support, and advanced longevity programmes.
Potential Advantages Over MSC Exosomes
Why we combine stem cells with exosomes
Combining live stem cells with exosome therapy creates a multi-layered regenerative approach. The stem cells provide ongoing cellular repair and integration at the treatment site, while exosomes deliver immediate, concentrated signalling that may accelerate the body's healing response. This combination allows us to target both the structural and biochemical aspects of tissue damage simultaneously.
Published research in journals such as Stem Cell Research & Therapy and Biomaterials has explored how combined MSC and exosome protocols may produce outcomes beyond what either therapy achieves alone. At Boston Health Longevity, your clinical team determines the optimal combination, dosing, and delivery method based on your specific condition and treatment goals.
30-150
Nanometre Size
1000+
Bioactive Proteins
150+
MicroRNA Types
Cell-Free
Therapy Approach
Exosome therapy is an emerging field of regenerative medicine. The benefits described are based on published preclinical and early clinical research. Individual outcomes may vary. Your clinical team will discuss the current evidence base during your consultation.
Which treatment combination is right for you?
Our clinical team at Boston Health Longevity will assess your condition and recommend the most appropriate protocol, including whether exosome therapy may enhance your treatment. No-obligation consultation. Most patients hear back within 24 hours.
Request AssessmentOur treatment process
Every patient follows a structured pathway designed to ensure thorough assessment, informed consent, and optimal care.
Initial Enquiry & Consultation
Submit your enquiry online or by phone. Our patient coordinators will arrange a remote consultation to discuss your condition and treatment goals.
Medical Records Review
Our clinical team reviews your medical history, imaging, and relevant records to assess preliminary suitability for treatment.
Travel & Arrival
We assist with travel planning, accommodation recommendations, and airport transfers to make your journey as smooth as possible.
On-Site Assessment
Comprehensive clinical evaluation including physical examination, diagnostic imaging, and blood work to confirm eligibility.
Treatment Day
Cell preparation, quality verification, and targeted delivery of UC-MSCs performed by experienced clinicians under appropriate imaging guidance.
Recovery & Monitoring
Post-procedure observation, discharge planning, and guidance for your recovery period in Chiang Mai.
Long-Term Follow-Up
Structured remote follow-up consultations at 1, 3, 6, and 12 months to monitor progress and provide ongoing support.
Have questions about treatment?
The clinical team at Boston Health Longevity is available to discuss your condition and whether stem cell therapy may be right for you.
Apply for ConsultationConditions we assess
We evaluate patients with a range of conditions to determine whether stem cell therapy may be appropriate.
Knee Arthritis
Knee arthritis causes progressive cartilage loss, chronic pain, and reduced mobility that worsens over time. For million...
Multiple Sclerosis (MS)
Multiple sclerosis is a complex autoimmune condition where the immune system attacks the protective myelin sheath around...
Spine Injury
Spinal injuries, disc degeneration, and chronic back pain affect millions worldwide. When conservative treatments fail a...
Hip Osteoarthritis
Hip osteoarthritis progressively destroys cartilage, causing pain, stiffness, and declining mobility. For many patients,...
Shoulder & Rotator Cuff
Rotator cuff injuries, shoulder impingement, and chronic tendinopathy cause persistent pain and limited function. Surgic...
Autoimmune Conditions
Autoimmune conditions, including rheumatoid arthritis, lupus, and inflammatory bowel disease, occur when the immune syst...
Parkinson's Disease
Parkinson's disease is a progressive neurodegenerative disorder characterised by tremor, rigidity, bradykinesia, and pos...
Alzheimer's & Dementia
Alzheimer's disease and related dementias cause progressive cognitive decline, memory loss, and functional impairment. C...
Cosmetic Rejuvenation
Cosmetic rejuvenation using stem cell therapy harnesses the regenerative properties of mesenchymal stem cells to support...
Biological Age Reversal
Biological ageing is driven by cellular decline, chronic inflammation, immune senescence, and stem cell exhaustion. Biol...
Nerve Damage & Neuropathy
Peripheral neuropathy and nerve damage cause debilitating symptoms including chronic pain, numbness, tingling, and loss ...
Chronic Pain & Fibromyalgia
Chronic pain and fibromyalgia are complex conditions characterised by widespread musculoskeletal pain, fatigue, sleep di...
Ankle Osteoarthritis
Ankle osteoarthritis is a degenerative condition characterised by progressive cartilage loss in the tibiotalar joint, le...
Cartilage Damage & Repair
Articular cartilage has limited capacity for self-repair due to its avascular nature, meaning injuries and wear often pr...
Meniscus Tear
Meniscus tears are among the most common knee injuries, occurring in athletes and ageing populations alike. The meniscus...
Tendon Injuries
Tendon injuries, including chronic tendinopathy, partial tears, and degenerative tendon disease, are notoriously difficu...
Ligament Injuries
Ligament injuries , from sprains to partial tears, compromise joint stability and can lead to chronic instability, recur...
Joint Inflammation
Chronic joint inflammation, whether from osteoarthritis, post-traumatic arthritis, inflammatory arthropathies, or overus...
Sports Injuries
Sports injuries, including muscle tears, tendon damage, ligament sprains, cartilage injuries, and stress fractures, can ...
Muscle Strains & Tears
Muscle strains and tears range from minor fibre disruption to significant structural tears that can take months to heal....
Rheumatoid Arthritis (Early-Stage)
Rheumatoid arthritis (RA) is a chronic autoimmune disease where the immune system attacks the synovial lining of joints,...
Chronic Joint Degeneration
Chronic joint degeneration encompasses the progressive deterioration of joint structures, cartilage, bone, synovium, and...
Psoriasis
Psoriasis is a chronic autoimmune condition characterised by accelerated skin cell turnover, leading to thick, scaly pla...
Lupus (Systemic Lupus Erythematosus)
Systemic lupus erythematosus (SLE) is a complex autoimmune disease in which the immune system produces antibodies that a...
Crohn's Disease
Crohn's disease is a chronic inflammatory bowel disease (IBD) that can affect any part of the gastrointestinal tract, mo...
Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory bowel disease characterised by continuous mucosal inflammation of the colon...
Chronic Systemic Inflammation
Chronic systemic inflammation is increasingly recognised as a driver of numerous degenerative conditions, accelerated ag...
Immune Dysregulation
Immune dysregulation encompasses a spectrum of conditions where the immune system functions abnormally, either overactiv...
Post-Stroke Recovery
Stroke causes acute damage to brain tissue through ischaemia or haemorrhage, resulting in motor deficits, speech impairm...
Age-Related Cognitive Decline
Age-related cognitive decline involves a gradual reduction in memory, processing speed, executive function, and mental c...
Chronic Fatigue Syndrome
Chronic fatigue syndrome (myalgic encephalomyelitis / CFS) is a complex, debilitating condition characterised by profoun...
Ischemic Heart Disease
Ischemic heart disease occurs when reduced blood flow to the heart muscle causes progressive damage, leading to angina, ...
Post-Heart Attack Recovery
A myocardial infarction (heart attack) causes irreversible death of heart muscle cells, replaced by scar tissue that imp...
Peripheral Vascular Disease
Peripheral vascular disease (PVD), including peripheral arterial disease (PAD), involves progressive narrowing and occlu...
Microvascular Dysfunction
Microvascular dysfunction involves impairment of the small blood vessels (arterioles, capillaries, venules) that supply ...
Type 2 Diabetes Support
Type 2 diabetes is a progressive metabolic disorder characterised by insulin resistance and declining beta-cell function...
Metabolic Syndrome
Metabolic syndrome is a cluster of interconnected conditions, central obesity, insulin resistance, dyslipidaemia, and hy...
Hormonal Imbalance
Hormonal imbalances, whether age-related, stress-induced, or linked to underlying endocrine dysfunction, affect energy l...
Age-Related Metabolic Decline
Age-related metabolic decline is a natural but increasingly well-understood process involving reduced mitochondrial func...
COPD (Chronic Obstructive Pulmonary Disease)
Chronic obstructive pulmonary disease (COPD) is a progressive inflammatory lung condition characterised by airflow limit...
Pulmonary Fibrosis
Pulmonary fibrosis is a serious condition characterised by progressive scarring (fibrosis) of lung tissue, leading to ir...
Chronic Inflammatory Lung Conditions
Chronic inflammatory lung conditions, including severe asthma, bronchiectasis, chronic bronchitis, and post-infectious l...
Hair Thinning & Hair Loss
Hair thinning and hair loss, whether from androgenetic alopecia, stress-related telogen effluvium, or autoimmune alopeci...
Burn Recovery
Burn injuries cause complex tissue damage involving destruction of skin layers, underlying structures, and disruption of...
Chronic Wound Healing
Chronic wounds, including diabetic ulcers, venous ulcers, pressure ulcers, and post-surgical wounds that fail to heal, r...
Scar Tissue Repair
Pathological scarring, including hypertrophic scars, keloids, and fibrotic contractures, results from dysregulated wound...
Immune Modulation Therapy
The immune system is a complex network that, when dysregulated, can contribute to a wide range of chronic conditions, fr...
Telomere & Longevity Protocols
Telomeres, the protective caps at the ends of chromosomes, shorten with each cell division, serving as a biological cloc...
Recovery from Physical Stress
Intense physical stress, whether from elite athletic training, demanding occupations, or accumulated physical strain, cr...
Post-Viral Illness Recovery
Post-viral syndromes, including long COVID, post-infectious fatigue, and other persistent symptoms following viral illne...
Immune Depletion Recovery
Immune depletion can result from aggressive medical treatments such as chemotherapy, prolonged immunosuppressive therapy...
High-Performance Optimisation
High-performance optimisation represents the frontier of regenerative medicine, using mesenchymal stem cell therapy not ...
Why Thailand for stem cell therapy?
Thailand has established itself as a leading destination for international healthcare, combining clinical expertise with exceptional patient care.
Experienced Clinicians
Board-certified medical professionals with specialised training in regenerative medicine.
International Standards
Modern clinical facilities meeting international healthcare standards.
Cost-Effective Care
Internationally competitive pricing for treatments often unavailable in patients' home countries.
Dedicated Patient Support
English-speaking coordinators, travel assistance, and comprehensive follow-up.
Recovery Environment
World-class hospitality and comfortable accommodation for post-treatment recovery.
Transparent Approach
Honest assessment of suitability with no pressure to proceed.
Our commitment to safety
Patient safety is our highest priority. Every treatment protocol includes thorough screening, informed consent, and ongoing monitoring. We maintain strict clinical standards and are transparent about both the potential benefits and limitations of stem cell therapy.
Learn About Safety & RegulationMedical Disclaimer
The information on this page is for educational purposes only and does not constitute medical advice. Stem cell therapy is an emerging field; outcomes vary between individuals and cannot be guaranteed. No claims of cure or specific results are made. Always consult with a qualified healthcare provider before making treatment decisions. Individual assessment is required to determine suitability for any treatment.
Ready to explore your options?
Book a no-obligation consultation with Boston Health Longevity to discuss your condition and treatment options. We respond within 24 hours.
Apply for ConsultationBrowse treatments & resources
Conditions We Treat
- Burn Recovery
- Autoimmune Conditions
- Ischemic Heart Disease
- Immune Depletion Recovery
- Biological Age Reversal
- Hormonal Imbalance
- Ankle Osteoarthritis
- Alzheimer's & Dementia
- Chronic Pain & Fibromyalgia
- Stem Cell High-Performance Optimisation
- Chronic Inflammatory Lung Conditions
- Recovery from Physical Stress